BELGOPHARMA

Active

Private limited companyfounded 20215 yrs activeBergense Steenweg 1160, 1070 Anderlecht, BelgiumKBO/BCE: BE 0762.935.682

Summary

The computed 12-month bankruptcy probability of BELGOPHARMA is 2.0% (moderate). The 2025 annual accounts show equity of €2.7m and a net result of €412,067. Equity is growing by ~129.9% per year across the filed fiscal years. Its solvency ranks better than 80% of 5451 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch Report Compare

BELGOPHARMAActiveChecked score 77/100

Risk analysis Report Compare

What they do

Wholesale of pharmaceutical and medical goods

NACE 46460

1 site

How big

€3.6mtotal assets 2025

Equity: €2.7m
Profit: €412,067

Financially healthy?

77 Excellent Checked score 2025

Bankruptcy chance 12 m: 2.0%

Who decides

Accounts 9 d early0 of 2 deeds read

Why 77- Limited track record- Higher-failure-rate region- Higher-failure-rate sector+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2025

77 / 100

Excellent

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability83▼-17

Solvency99▲+6

Growth78=

Track record94

Bankruptcy probability, 12 months

2.0% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €200,000 at 30 days acceptable

Liquidity ample (current ratio 3.14 against 3.13 in 2024; short-term debt: 26.3% and cash: 36.6% of total assets), and 26.4% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

73.6%

Return on assets

11.3%

Age of the figures

9 mo

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 46

Relative position

BE, all sectors

reference

Wholesale trade (NACE 46)

about 21% more bankruptcies

← fewer bankruptcies more bankruptcies →

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.

NBB · 5 filings

Deviation from the deadline

2025

9 d early

2024

29 d late

2023

25 d late

2022

30 d late

2021

30 d late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 21 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 29 August (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Position in the running window

02-10-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage